It’s had to raise money from share issues or investment every year since 2005. Now it’s that time of year again... Behavioural ad targeter Phorm says it’s moving operational activities to Brazil, where it has its solitary customer and is seeking local equity investors for yet another fundraising.

The European Commission has told Britain to change its laws, after concluding it incorrectly applied European rules in allowing the go-ahead of controversial behavioural ad targeter Phorm, which will monitor an ISP customer’s every web click to better target ads on partner websites. The EC’s complaint (see statement) seems to…

Phorm claims it could transform the way ISPs and online publishers monetise the web. But we’re still no closer to finding out when the company’s controversial software will be commercially deployed in the UK or elsewhere. The company held a “town hall” style meeting at the London School of Economics…

Update: Phorm’s CEO Kent Ertugrul later told me in an interview that the Korean deal is the result of talks with ISPs “around the world” going back as far as three years and that deals in other countries would be gradually signed as the company grows—he says it might be…

As it steps up its campaign to convince the nation that behavioural targeting isn’t such a bad thing, still-to-be-deployed ISP-based ad outfit Phorm has made two senior appointments. Sarah Simon comes in as financial and strategic development officer, joining from Morgan Stanley, while former digital general manager at Telegraph Media…

Platform-A, AOL’s recently unified collection of advertising businesses, has distanced itself from behavioural targeting rival Phorm, although the two were amongst signatories to a new code on the practice last week. While as-yet-unlaunched, ISP-based Phorm can target ads based on all users’ browsing habits, Platform-A’s Tacoda behavioural targeting unit relies…

The retraction came in so quick, we hadn’t even seen the original press release. Under legal pressure, consumer mag Which? on Wednesday hastily called back a survey it issued indicating public opposition to on-ISP behavioural ad targeter Phorm. Which? sent the following statement… “Urgent withdrawal of press release from Which?…

After BT (NYSE: BT) concluded its much-delayed trial of Phorm‘s controversial ISP-based behavioural ad targeting technology in December, the advertising company is trying to keep those precious few positive moments up in the spotlight. “We’re not able to comment on specific timings but our work with BT is the most…

Phorm’s CEO has appeared to refute a suggestion the on-ISP behavioural ad targeter may pay users to sign up to the service. NMA said Phorm “is undertaking research to discover what kind of offers users would regard as valuable enough to sign up”. But Kent Ertugrul, in a briefing with…

What is going on at Phorm? The behavioural targeting ad network announced that three more senior executive are leaving - UK chief executive Hugo Drayton will be gone from the post by year’s end, leaving “by mutual consent” just two weeks after four board members and the COO walked out…

BT (NYSE: BT) has concluded its delayed trial of the controversial behavioural ad targeter Phorm and hopes to roll out the service to its ISP customers. Phorm told the market this morning: “The trial achieved its primary objective of testing all the elements necessary for a larger deployment, including the…

Further instability hits behavioural targeting advertiser Phorm: its four board members Stephen Meyer, Virasb Vahidi, David Dorman and Christopher Lawrence have quit “with immediate effect”. In a statement, Phorm said the four “will take this action as a result of differences with (CEO Kent) Ertugrul (pictured) as to the management…

Behavioural ad targeting network Phorm may still have the three ISP agreements it won in February - but, unlike BT (NYSE: BT), whose delayed trial is now underway, it seems a case of “if”, not when, Virgin Media (NSDQ: VMED) will go ahead with the partnership. —First inkling we got…

That trial couldn’t come quick enough. Controversial behavioural ad targeter Phorm’s half-year losses grew from $16.3 million (£9.04 million) to $24.7 million (£13.7 million) in the first half of this year. BT’s trial of the service starts today after a delay of several months, with TalkTalk and Virgin Media (NSDQ:…

A month or two after it was due to commence, BT’s (NYSE: BT) trial of the controversial on-net behavioural ad targeter Phorm will finally start Tuesday morning. Earlier this month, Phorm conceded prepping the trial had “taken longer than originally anticipated”, but this morning it told the market its service…

Behavioral ad targeter Phorm will be allowed to operate its ad serving system in the UK, but regulators say the company must adhere to a strict set of rules, BBC reported. While Phorm can roll out its ad targeting system, UK officials the company must seek users’ consent first and…

Controversial on-ISP behavioural ad targeting outfit Phorm had been due to start its trial on BT’s (NYSE: BT) broadband network weeks ago, but we hadn’t heard a sniff of it actually happening. This morning, Phorm confirmed the delay by issuing a regulatory notice to the market: “Whilst this has taken…

Controversial ISP-based behavioural ad targeter Phorm has handed its chairmanship to former Coca-Cola and Turner Broadcasting System president Steven J. Heyer. CEO Kent Ertugrul is handing over the chairman role but continuing in the top spot. Heyer joined the board in October and is also CEO of animator Fathom Studios…

Despite the controversy that’s been kicked up, BT is going ahead with more trials in the coming weeks with Phorm, the behavioural ad technology firm that has developed software that tracks consumers surfing habits online inorder to deliver more targeted advertising to them, reports the Ft.com. BT has been eager…